Drug Approval | July 10, 2023
Astellas receives FDA priority review for Zolbetuximab biologics license application
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Oncodesign Services and ImaginAb sign a Preclinical License and Supply Agreement
Based on a subgroup analysis by PD-L1 expression from KEYNOTE-811, Merck is working with the US FDA to update the current indication for KEYTRUDA in HER2-positive gastric or GEJ adenocarcinoma
Ministry of Health, Labour and Welfare to evaluate zolbetuximab as treatment option for patients with advanced gastric and gastroesophageal cancers
The new Biolys provides higher concentration of L-lysine
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
The new team members, Solenn Percelay and Noémie Spinelli, will support the organization’s commitment to excellence in humanized mouse model care and use
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
Subscribe To Our Newsletter & Stay Updated
